Who
Martin I. Freed
Director
Company insider
Files Form 4 as: Director, Solid Biosciences; Director, Dicerna Pharmaceuticals.
In numbers
- Trades disclosed
- 33
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 2
- Companies where not an officer
- 2
- First trade
- 14 Jun 2016
- Last trade
- 10 Jun 2026
- Last filed
- 11 Jun 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 10 Jun 2026filed 11 Jun 2026 | SLDB Solid Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —77,500 at $0.00 | filing |
| 10 Jun 2026filed 11 Jun 2026 | SLDB Solid Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —77,500 at $0.00 | filing |
| 12 Jun 2025filed 13 Jun 2025 | SLDB Solid Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —77,500 at $0.00 | filing |
| 11 Jun 2024filed 13 Jun 2024 | SLDB Solid Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —34,400 at $0.00 | filing |
| 6 Jun 2023filed 8 Jun 2023 | SLDB Solid Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —9,650 at $0.00 | filing |
| 13 Dec 2022filed 15 Dec 2022 | SLDB Solid Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —9,650 at $0.00 | filing |
| 7 Jun 2022filed 9 Jun 2022 | SLDB Solid Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —51,000 at $0.00 | filing |
| 28 Dec 2021filed 29 Dec 2021 | Dicerna Pharmaceuticalsoption or derivative | SEC FORM 4 Code D | —3,333 | filing |
| 28 Dec 2021filed 29 Dec 2021 | Dicerna Pharmaceuticalsoption or derivative | SEC FORM 4 Code D | —25,000 | filing |
| 28 Dec 2021filed 29 Dec 2021 | Dicerna Pharmaceuticalsoption or derivative | SEC FORM 4 Code D | —25,000 | filing |
| 28 Dec 2021filed 29 Dec 2021 | Dicerna Pharmaceuticalsoption or derivative | SEC FORM 4 Code D | —25,000 | filing |
| 28 Dec 2021filed 29 Dec 2021 | Dicerna Pharmaceuticalsoption or derivative | SEC FORM 4 Code D | —25,000 | filing |
| 28 Dec 2021filed 29 Dec 2021 | Dicerna Pharmaceuticalsoption or derivative | SEC FORM 4 Code D | —15,000 | filing |
| 28 Dec 2021filed 29 Dec 2021 | Dicerna Pharmaceuticalsoption or derivative | SEC FORM 4 Code D | —15,000 | filing |
| 28 Dec 2021filed 29 Dec 2021 | Dicerna Pharmaceuticals | SEC FORM 4 Code U | $127K3,333 at $38.25 | filing |
| 16 Jun 2021filed 21 Jun 2021 | SLDB Solid Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —30,000 at $0.00 | filing |
| 3 Jun 2021filed 7 Jun 2021 | Dicerna Pharmaceuticals | SEC FORM 4 Code M | —3,333 | filing |
| 3 Jun 2021filed 7 Jun 2021 | Dicerna Pharmaceuticalsoption or derivative | SEC FORM 4 Code M | —3,333 at $0.00 | filing |
| 3 Jun 2021filed 7 Jun 2021 | Dicerna Pharmaceuticalsoption or derivative | SEC FORM 4 Code A | —3,333 at $0.00 | filing |
| 3 Jun 2021filed 7 Jun 2021 | Dicerna Pharmaceuticalsoption or derivative | SEC FORM 4 Code A | —15,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.